Liver type I regulatory T cells suppress germinal center formation in HBV-tolerant mice

Significance We present a unique study of a liver-induced systemic tolerance using an intact virus, other than a single protein component-induced liver-persistent model. Liver-educated regulatory cells migrate into peripheral sites and mediate the systemic tolerance. Kupffer cells induce the generation of type 1-like regulatory cells in an IL-10–dependent manner. A possible role of type 1-like regulatory cells in suppressing germinal center formation via secreting IL-10 is demonstrated. We observed that a “regulatory cell-based” tolerizing mechanism, rather than a “clonal deletion” mechanism, provides the possibility of reversing the tolerance by immunotherapeutic approaches. The liver plays a critical role in inducing systemic immune tolerance, for example, during limiting hypersensitivity to food allergy and in rendering acceptance of allotransplant or even hepatotropic pathogens. We investigated the unknown mechanisms of liver tolerance by using an established hepatitis B virus (HBV)-carrier mouse model, and found that these mice exhibited an antigen-specific tolerance toward peripheral HBsAg vaccination, showing unenlarged draining lymph node (DLN), lower number of germinal centers (GC), and inactivation of GC B cells and follicular T helper (Tfh) cells. Both in vivo and in vitro immune responses toward HBsAg were suppressed by mononuclear cells from HBV-carrier mice, which were CD4+ Foxp3− type 1 regulatory T (Tr1)-like cells producing IL-10. Using recipient Rag1−/− mice, hepatic Tr1-like cells from day 7 of HBV-persistent mice acquired the ability to inhibit anti-HBV immunity 3 d earlier than splenic Tr1-like cells, implying that hepatic Tr1-like cells were generated before those in spleen. Kupffer cell depletion or IL-10 deficiency led to impairment of Tr1-like cell generation, along with breaking HBV persistence. The purified EGFP+CD4+ T cells (containing Tr1-like cells) from HBV-carrier mice trafficked in higher numbers to DLN in recipient mice after HBsAg vaccination, and subsequently inactivated both Tfh cells and GC B cells via secreting IL-10, resulting in impaired GC formation and anti-HB antibody production. Thus, our results indicate Tr1-like cells migrate from the liver to the DLN and inhibit peripheral anti-HBV immunity by negatively regulating GC B cells and Tfh cells.

[1]  Z. Tian,et al.  Therapeutic recovery of hepatitis B virus (HBV)‐induced hepatocyte‐intrinsic immune defect reverses systemic adaptive immune tolerance , 2013, Hepatology.

[2]  Clelia Di Serio,et al.  Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells , 2013, Nature Medicine.

[3]  R. Sun,et al.  Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice. , 2013, Gastroenterology.

[4]  D. Roos,et al.  The cytokines interleukin 27 and interferon-γ promote distinct Treg cell populations required to limit infection-induced pathology. , 2012, Immunity.

[5]  Carola G. Vinuesa,et al.  Foxp3(+) follicular regulatory T cells control the germinal centre response , 2012 .

[6]  Laurence A. Turka,et al.  Faculty Opinions recommendation of Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. , 2011 .

[7]  Percy A. Knolle,et al.  Antigen-presenting cell function in the tolerogenic liver environment , 2010, Nature Reviews Immunology.

[8]  Kuender D Yang,et al.  Oral tolerance to food-induced systemic anaphylaxis mediated by the C-type lectin SIGNR1 , 2010, Nature Medicine.

[9]  Ding‐Shinn Chen,et al.  Hepatitis B virus core antigen determines viral persistence in a C57BL/6 mouse model , 2010, Proceedings of the National Academy of Sciences.

[10]  B. Weynand,et al.  In Vivo Induction of Type 1-Like Regulatory T Cells Using Genetically Modified B Cells Confers Long-Term IL-10-Dependent Antigen-Specific Unresponsiveness1 , 2009, The Journal of Immunology.

[11]  M. Atkinson,et al.  Antigen-Specific Dependence of Tr1-Cell Therapy in Preclinical Models of Islet Transplant , 2009, Diabetes.

[12]  S. Chouzenoux,et al.  Increased Expression of Regulatory Tr1 Cells in Recurrent Hepatitis C after Liver Transplantation , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  James M. Wilson,et al.  Hepatic regulatory T cells and Kupffer cells are crucial mediators of systemic T cell tolerance to antigens targeting murine liver , 2009, Hepatology.

[14]  M. A. Curotto de Lafaille,et al.  Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? , 2009, Immunity.

[15]  Daniel J. Campbell,et al.  T-bet controls regulatory T cell homeostasis and function during type-1 inflammation , 2009, Nature Immunology.

[16]  I. N. Crispe,et al.  The liver as a lymphoid organ. , 2009, Annual review of immunology.

[17]  R. Sun,et al.  NKG2D–retinoic acid early inducible‐1 recognition between natural killer cells and kupffer cells in a novel murine natural killer cell–dependent fulminant hepatitis , 2009, Hepatology.

[18]  W. Brück,et al.  Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs. , 2008, The Journal of clinical investigation.

[19]  R. Kedl,et al.  Mechanism of T cell tolerance induction by murine hepatic Kupffer cells , 2008, Hepatology.

[20]  Zhigang Tian,et al.  Liver: An organ with predominant innate immunity , 2007, Hepatology.

[21]  R. Herzog,et al.  Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer. , 2007, Blood.

[22]  V. Benseler,et al.  T cells in the liver: There is life beyond the graveyard , 2007, Hepatology.

[23]  Ding‐Shinn Chen,et al.  An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection , 2006, Proceedings of the National Academy of Sciences.

[24]  B. John,et al.  Cellular and molecular mechanisms of liver tolerance , 2006, Immunological reviews.

[25]  R. Herzog,et al.  Prevention of cytotoxic T lymphocyte responses to factor IX-expressing hepatocytes by gene transfer-induced regulatory T cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Sun,et al.  Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism. , 2006, Journal of hepatology.

[27]  E. Bonifacio,et al.  Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. , 2006, Diabetes.

[28]  R. Herzog,et al.  Induction of antigen-specific CD4+ T-cell anergy and deletion by in vivo viral gene transfer. , 2004, Blood.

[29]  H. Groux,et al.  Specialization in tolerance: innate CD4+CD25+ versus acquired TR1 and TH3 regulatory T cells.1 , 2004, Transplantation.

[30]  B. Collins,et al.  Kupffer cells: Another player in liver tolerance induction , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[31]  N. Netzer,et al.  Tr1 cell-dependent active tolerance blunts the pathogenic effects of determinant spreading. , 2002, The Journal of clinical investigation.

[32]  G. McCaughan,et al.  Role of primary intrahepatic T‐cell activation in the ‘liver tolerance effect’ , 2002, Immunology and cell biology.

[33]  D. Metz,et al.  The liver as a site of T‐cell apoptosis: graveyard, or killing field? , 2000, Immunological reviews.

[34]  Hervé Groux,et al.  A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.

[35]  R. Binns,et al.  Induction of Immunological Tolerance by Porcine Liver Allografts , 1969, Nature.